NAS:ALPN (USA) Also Trade In: Germany
Alpine Immune Sciences Inc $ 7.82 -0.85 (-9.8%)
Warning! GuruFocus has detected 2 Severe warning signs with ALPN. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Alpine Immune Sciences Inc () from 2015 to Sep 21 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Alpine Immune Sciences stock (ALPN) PE ratio as of Sep 21 2020 is 0. More Details
Alpine Immune Sciences PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Alpine Immune Sciences PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:INMB AMEX:ARMP NAS:VCNX OTCPK:EMMA NAS:ONTX NAS:CLGN OTCPK:ELTP NAS:DMAC NAS:IDRA NAS:ITRM OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 188 East Blaine Street, Suite 200, Seattle, WA, USA, 98102
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing modern, protein-based immunotherapies targeting the immune synapse to treat cancer, inflammation, and other diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202.